MEDA
This article relies largely or entirely on a single source. (July 2019) |
![]() | |
Names | |
---|---|
Preferred IUPAC name 1-(8-Methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
KEGG | |
PubChem CID | |
UNII | |
| |
| |
Properties | |
C12H17NO3 | |
Molar mass | 223.272 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
MEDA (3-methoxy-4,5-ethylenedioxyamphetamine) is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown.[1] MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.
See also
[edit]References
[edit]